Understand the source comparison
How Much DSIP Per Day Daily Dose: Research vs Therapeutic Context
25–50 mcg Minimum effective dose in early animal studies Mild reduction in sleep latency, minimal slow-wave sleep increase 7–14 days Subtherapeutic in most human protocols. Used primarily for dose-response characterization 100–150 mcg Standard human research d
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- 25–50 mcg
- Minimum effective dose in early animal studies
- Mild reduction in sleep latency, minimal slow-wave sleep increase
- 7–14 days
- Subtherapeutic in most human protocols. Used primarily for dose-response characterization
- 100–150 mcg
- Standard human research dose
- 15–25% increase in Stage 3/4 sleep, reduced waking after sleep onset
- 14–28 days
- Most reproducible dose range across published trials. Baseline for comparison studies
- 200–300 mcg
- Upper therapeutic range
- Marginal additional benefit over 150 mcg, increased reports of morning grogginess
- 14–21 days
- Diminishing returns. Efficacy plateaus while side effect frequency increases
- 400–500 mcg
- Supraphysiological dose
- Paradoxical activation in some subjects, no improvement in sleep architecture
- Single-dose or 3–7 days
- Exceeds receptor saturation. Produces inconsistent results and is outside standard protocols
- Daily vs alternate-day
- Comparison design
- Daily dosing shows cumulative adaptation by day 10–14; alternate-day shows no tolerance
- 21–28 days
- Daily administration is standard, but some protocols use 5 days on / 2 days off to prevent receptor desensitization